Science 37 raises $31M in series B

Science 37 Inc. (Culver City, Calif.) raised $31 million in a series B financing led by Redmile Group. Existing investors Lux Capital and dRx Capital also participated, as well as Sanofi Genzyme BioVentures.

The company is developing a decentralized approach for conducting clinical trials, which it says will allow sponsors to cut costs through streamlined studies. Using a cloud-based connection platform, Science 37 seeks to replace clinical trial locations with "metasites" that use telemedicine and doctor home visits to give patients access to trials. ...